Stockscreener 앱 받기
20.33
5.94%
1.1998
Uniqure Nv 주식(QURE)의 최신 뉴스
uniQure’s AMT-130 Regulatory Progress Sharpens Huntington’s Disease Investment Case - Yahoo Finance
UniQure plummets as FDA calls for phase 3 trial for Huntington's asset AMT-130 - MSN
Jennison Associates LLC Boosts Stake in uniQure N.V. $QURE - MarketBeat
Update: UniQure Shares Rise After Firm Plans to Submit UK Marketing Application for Huntington's Disease Treatment - Moomoo
symbol__ Stock Quote Price and Forecast - CNN
uniQure (QURE) Shares Surge 22% on Positive Regulatory News for AMT-130 - GuruFocus
MSN Money - MSN
uniQure NV | SCHEDULE 13G/A: Others - Moomoo
UniQure Plans to Submit UK Marketing Authorization Application for Huntington's Disease Treatment - Moomoo
uniQure stock rises after regulatory updates (QURE:NASDAQ) - Seeking Alpha
UniQure, in ‘symbolic’ win, to seek UK approval of Huntington’s gene therapy - BioPharma Dive
uniQure (NASDAQ:QURE) Shares Gap UpHere's Why - MarketBeat
uniQure plans UK filing for Huntington’s gene therapy AMT-130 By Investing.com - Investing.com India
QURE Stock Just Shot Up 8%uniQure’s Much-Talked-About Huntington’s Disease Therapy Gets A UK Boost - Stocktwits
uniQure meets with UK MHRA on AMT-130 for Huntington’s disease - The Pharma Letter
Aberdeen Group (QURE) reports 5.31M shares, 8.49% stake | Schedule 13G/A - Stock Titan
uniQure advances AMT-130 toward UK marketing approval - TipRanks
uniQure plans UK filing for Huntington’s gene therapy AMT-130 - Investing.com
uniQure NV | 8-K: Current report - Moomoo
AMT-130 Huntington’s gene therapy nears UK filing for uniQure (NASDAQ: QURE) - Stock Titan
uniQure Announces Successful UK MHRA Pre-Submission Meeting for AMT-130 in Huntington’s Disease - GlobeNewswire
Earnings Preview: UniQure NV to Report Financial Results Pre-market on May 05 - 富途牛牛
QURE stock crashes 32% in a week: Here's what you should know - MSN
H.C. Wainwright Maintains UniQure NV(QURE.US) With Buy Rating, Maintains Target Price $70 - Moomoo
uniQure N.V. (NASDAQ:QURE) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
UniQure used 'distorted comparison' in Huntington's asset trial: FDA official - MSN
UniQure surges following departure of key FDA official - MSN
Before the bell, uniQure posts Q1 numbers and takes questions May 5 - Stock Titan
uniQure to Announce First Quarter 2026 Financial Results - Sahm
uniQure NV (MEX:QUREN) Stock Earnings Transcripts - GuruFocus
uniQure (NASDAQ: QURE) outlines 2026 proxy agenda, equity and charter changes - Stock Titan
[ARS] uniQure N.V. SEC Filing - Stock Titan
(QURE) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
uniQure announces $200 million proposed public offering - MSN
QURE Forecast, Price Target & Analyst Ratings | UNIQURE NV (NASDAQ:QURE) - ChartMill
QURE SHAREHOLDER NOTICE: Hagens Berman Updates uniQure (QURE) Investigation Following Public FDA Rebukes and Allegations of "Distorted" Data (PR Newswire) - Aktiellt
uniQure N.V. (QURE) Stock Outlook | Q4 2025: Profit Exceeds ViewsROCE - Xã Châu Thành
uniQure N.V. (QURE) Stock Posts 30% Growth from Last Year - Insider Monkey
QURE Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
uniQure NV (MEX:QUREN) Short-term investments - GuruFocus
Barclays reaffirms equal weight rating for uniQure (QURE) - MSN
uniQure Shares Collapse 75% After FDA Reverses Position on Huntington’s Therapy - MSN
QURE Maintained by Goldman Sachs -- Price Target Raised to $10.0 - GuruFocus
uniQure N.V. (QURE) Stock: Fair Value Assessment (Extends Gains) 2026-04-20Trade Ideas - Cổng thông tin điện tử tỉnh Tây Ninh
uniQure N.V. (QURE) Stock Virtual Order (+4.58%) 2026-04-18Community Volume Signals - Cổng thông tin điện tử Tỉnh Sơn La
uniQure NV Stock Operating Data - GuruFocus
uniQure NV (MEX:QUREN) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
uniQure NV (MEX:QUREN) Stock HoldersInstitutional & Insider Ownership - GuruFocus
Q4 2025 Uniqure NV Earnings Call Transcript - GuruFocus
uniQure NV (MEX:QUREN) Stock Price & 30 Year Financial Data - GuruFocus
Uniqure NV at TD Cowen Healthcare Conference Transcript - GuruFocus
Total debt per share of uniQure N.V. – SWB:UQ1 - TradingView
uniQure N.V. (NASDAQ:QURE) Sees Significant Decrease in Short Interest - MarketBeat
0.83%
2.04%
자본화:
|
볼륨(24시간):